Latest Hyperuricemia Stories
A new study shows the prevalence of gout in the U.S. has risen over the last twenty years and now affects 8.3 million (4%) Americans.
WASHINGTON and DEERFIELD, Ill., June 28, 2011 /PRNewswire/ -- Men's Health Network (MHN) and Takeda Pharmaceuticals North America, Inc., today announced a partnership to launch the "Gout Pit Stop," an educational campaign to raise awareness about gout, a type of arthritis that affects approximately 8.3 million people in the U.S.
EAST BRUNSWICK, N.J., May 26, 2011 /PRNewswire/ -- Savient Pharmaceuticals, Inc.
LONDON, May 25, 2011 /PRNewswire/ -- Ardea Biosciences, Inc.
HAYWARD, Calif., May 19, 2011 /PRNewswire/ -- Metabolex, Inc., a biopharmaceutical company focused on the discovery and development of proprietary new medicines for the treatment of metabolic diseases, announced today that it has initiated a Phase 2 clinical trial of arhalofenate (MBX-102), its product candidate for the management of hyperuricemia in patients with gout. This randomized, double-blind, placebo-controlled study will evaluate the safety and urate-lowering activity of 400 and 600...
CLEVELAND, May 17, 2011 /PRNewswire/ -- A new survey from the nonprofit Gout & Uric Acid Education Society (GUAES) highlights an alarming awareness gap among Americans regarding the risk factors for gout, a chronic, potentially disabling form of arthritis which now affects an estimated 8.3 million Americans.(1) Among the survey findings are that only one in 10 Americans correctly cited cardiovascular disease as a risk factor for gout, while only one in three Americans correctly reported...
EAST BRUNSWICK, N.J., May 4, 2011 /PRNewswire/ -- Savient Pharmaceuticals, Inc.
SAN DIEGO, April 25, 2011 /PRNewswire/ -- Ardea Biosciences, Inc.
SAN DIEGO, April 6, 2011 /PRNewswire/ -- Getting the word out about preventing and treating gouty arthritis has new urgency with the number of Americans suffering from this form of arthritis now topping the 8 million mark. If left untreated, gout can be disabling.
SAN DIEGO, Jan. 6, 2011 /PRNewswire/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA) today announced positive, preliminary, top-line results from its Phase 2b study of RDEA594 in combination with the current standard of care for the treatment of gout, allopurinol.
The Dalmatian is a coach dog which is easily recognized for its unique spotted coat. This ancient breed has been used as a guard dog, bird dog, trail hound, retriever, and most importantly a coach or carriage dog. The Dalmatian was once used to run in attendance on a coach. This ability was eventually transferred to its career as a firehouse dog. The Dalmatian once ran in front of horse-drawn fire carts to help clear a path for them as well as guide them to fires. The Dalmatian is a...
- A political dynamiter.